Comprehensive analyzes of the fastest-growing Europe Digital Therapeutics Market provide insights that help stakeholders identify opportunities and challenges. The markets of 2022 could be another significant year for Europe Digital Therapeutics. This report provides insight into the company’s activities and financial condition (a company profile is required if you wish to raise capital or attract investors), recent developments (mergers and acquisitions), and recent SWOT analyses. This report focuses on the Europe Digital Therapeutics market over the 2026 assessment period.
Download Report Sample with Industry Insights:
https://www.alliedmarketresearch.com/request-sample/6516
The Europe digital therapeutics market size was valued at $0.50 billion in 2018 and is expected to reach $2.27 billion by 2026 with a CAGR of 20.6% during the forecast period.
“The Europe digital therapeutics market is expected to grow at a faster rate during the forecast period, owing to increase in smart phone penetration. Moreover, rise in need to curb healthcare costs and increase in prevalence of chronic diseases are anticipated to supplement the market growth.”
Key Findings of the Study:
- Software is expected to be one of the most lucrative segments,registering a CAGR of 20.8% during the forecast period.
- The business-to-consumers (B2C)segmentaccounted for maximum share in the Europe market in 2018, and is expected to grow at a CAGR of 21.1% during the forecast period.
- UK dominated the Europe digital therapeutics market, and is projected to retain this trend throughout the forecast period.
- Diabetes is accounted for the maximum share in 2018, in Europe, with registering a CAGR of 22.6% during the forecast period.
Key Players Mentioned in the Europe Digital Therapeutics Market Research Report:
Ada Health GmbH, CogniFit, Caterna Vision GmbH, Fitbit, Inc. (Twine Health, Inc.), Kaia Health, Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), ResMed, Inc. (Propeller Health), Sonormed GmbH, and Voluntis, Inc.
Do Purchase Enquiry at:
https://www.alliedmarketresearch.com/purchase-enquiry/6516
Among applications, obesity segment is expected to grow at a high CAGR during the forecast period, owing to the increase in obese population. For instance, according to the WHO, in Europe, 58.7% of the population was overweight and 23.3% of population were obese in 2016, and this percentage is rising every year.
Amongproducts, in 2018, software segment helda dominant portion in the market,accounting for about 68.2% of Europe digital therapeutics market sharein 2018. This is mainly due to the increased penetration of smart phones and other devices mostly in developing economies. This further increases the use of digital therapeutics.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
Email: help@alliedmarketresearch.com
